Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
Status:
RECRUITING
Trial end date:
2026-01-30
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults.